Skip to content

Ardelyx ARDX Book value per share

Book value per share at other companies

Amgen logo
AmgenAMGN
$16.89+47.2%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$5.52-72.6%
AbbVie logo
AbbVieABBV
-$3.75-568%
XER
Xeris Biopharma Holdings, Inc.XERS
$0.07+132%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$0.97+6.7%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$32.95+33.2%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on the most recent quarter.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's book value per share?
Ardelyx (ARDX) reported book value per share of $0.60 in Q1 2026.
How has Ardelyx's book value per share changed year-over-year?
Ardelyx's book value per share decreased by 1.0% year-over-year, from $0.61 to $0.60.
What is the long-term trend for Ardelyx's book value per share?
Over 5 years (2020 to 2025), Ardelyx's book value per share has grown at a -13.2% compound annual growth rate (CAGR), from $1.41 to $0.69.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.